Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development

The National Institutes of Health, National Cancer Institute (NCI) is seeking support services to operate and maintain the National Cancer Institute's Chemotherapeutic Agents Repository (NCI-CAR) in Rockville, MD. This initiative, managed by the NCI Division of Cancer Treatment and Diagnosis Developmental Therapeutics Program, provides resources to academic and private-sector research communities to facilitate the discovery and development of new cancer therapeutic agents. The primary goals of this requirement are to support compound acquisition for the pre-clinical drug evaluation program, which focuses on identifying new small molecule therapeutic agents, and to manage the distribution of chemicals to intramural and extramural investigators for research purposes.

Contractual responsibilities include providing an informational interface for investigators submitting or requesting research compounds and maintaining a chemical database that tracks chemical data, inventor details, and shipping information. The selected contractor will perform systematic record keeping for both current and archival repository activities and manage the reacquisition of samples for continued chemical and biological studies. This requirement is classified under NAICS 541990, All Other Professional, Scientific, and Technical Services, and PSC R707, SUPPORT- MANAGEMENT: CONTRACT/PROCUREMENT/ACQUISITION SUPPORT.

Proposals for solicitation NCI-DCTD-23-0001 are due by June 13, 2022, following an extension and updates to the statement of work issued via Amendment 1. Erin Dwyer serves as the point of contact for this solicitation. The formal notice includes three attachments: a signed SF30-Amendment 1, a document containing 23 separate attachments, and a draft version of the solicitation.